期刊文献+

中美原料药、药用辅料和药包材的注册管理对比研究 被引量:1

Comparative on the Registration Management of Active Pharmaceutical Ingredient,Pharmaceutical Excipient and Pharmaceutical Packaging Material between China and the United States
下载PDF
导出
摘要 对中美两国原料药、药用辅料和药包材(以下简称“原辅包”)注册管理工作进行阐述和比较,包括政策和指导文件、产品适用范围和要求、登记(提交)和审查、变更和年报及关联审评程序等方面对比分析,旨在对我国原辅包注册管理工作的改进提供借鉴。 In order to put forward some suggestions on registration management in China,this paper made an systematically analysis&introduction on registration management of active pharmaceutical ingredient,pharmaceutical excipient and pharmaceutical packaging materials between China and the United States.The introduction includes relevant policies and guidance,application scope and corresponding requirement of product,registration(submission),review,change,annual reports and related evaluation procedures.
作者 王佳 袁利佳 张宁 WANG jia;YUAN li-jia;ZHANG ning(Center for Drug Evaluation,National Medicine Products Administration,Beijing 100022,China)
出处 《中国药物评价》 2021年第6期488-492,共5页 Chinese Journal of Drug Evaluation
关键词 原辅包 药品主文件 登记 关联审评 Packaging materials in direct contact with drugs Drug Master File Registration Bundling review
  • 相关文献

参考文献5

二级参考文献16

  • 1张象麟.DM(“美”的历程[N].医药经济报,2012-01-23(F02).
  • 2FDA.DMF lists[EB/OL].[2016-02-03].http://www.fda.gov/downloads/Drugs/DevelopmentA pprovalP rocess/FormsS ubmissionRequirements/DrugM asterF ilesD MFs/UCM370723.txt.
  • 3The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.Good manufacturing practice guide for active pharmaceutical ingredients[EB/OL].[2016-02-03].http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q7/Step4/Q7_Guideline.pdf.
  • 4FDA.Drug Master Files[EB/OL].[2016-02-03].http://www.fda.gov/drugs/developmentapprovalprocess/formssubmissionrequirements/drugmasterfilesdmfs/default.htm.
  • 5张象麟.备案管理制度的优方向[N].医药经济报,2012-07-16(F02).
  • 6FDA. Drug Master Files Guidelines[EB/OL]. [2016-02 - 03 ]. http ://www. fda. gov/drugs/guidancecompliance - regulatoryinformation/guidances/ucm122886, htm.
  • 7赵慧玲.浅谈已有国家标准的原料药的质量控制和管理[J].中国药事,2008,22(3):203-208. 被引量:5
  • 8药品注册管理办法[J].中国新药与临床杂志,2008,27(4):303-312. 被引量:13
  • 9韦冠.国内外药品上市许可制度比较及借鉴[J].中国药房,2008,19(34):2650-2653. 被引量:19
  • 10姚瑜嫔,陈永法,邵蓉,顾政.我国药品进入欧盟市场的策略研究[J].中国药业,2009,18(16):16-17. 被引量:1

共引文献9

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部